These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 11426497)

  • 21. [Results of polychemotherapy (a VMCP/VCAP program) in multiple myeloma].
    Wutke K; Anger G
    Z Gesamte Inn Med; 1983 Dec; 38(23):630-3. PubMed ID: 6689459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Systemic amyloidosis associated with IgD-λ multiple myeloma].
    Nagamachi Y; Yamauchi N; Muramatsu H; Inomata H; Nozawa E; Koyama R; Ihara K; Nishisato T; Yamada H; Yano T; Kikuchi S; Hirako T; Kitaoka K; Ono K; Ihara H; Kato J
    Rinsho Ketsueki; 2011 Dec; 52(12):1888-92. PubMed ID: 22241157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combined treatment, polychemotherapy and amino-hydroxybutylidene-diphosphonate, of a patient with multiple myeloma: remission and long survival].
    Attardo-Parrinello G; Merlini G; Crema F; Fiorentini ML; Mazzone A; Cotti-Piccinelli E
    Medicina (Firenze); 1988; 8(3):318-20. PubMed ID: 3231044
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination chemotherapy with MCNU, vindesine, melphalan, and prednisolone (MCNU-VMP therapy) in induction therapy for multiple myeloma. Japan Myeloma Study Group.
    Imamura Y; Takagi T; Yawata Y; Nishinarita S; Kosaka M; Mikuni C; Takatsuki K; Sezaki T; Mori M; Tsuchiya J
    Int J Hematol; 1994 Feb; 59(2):113-23. PubMed ID: 8018904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of vincristine, melphalan, cyclophosphamide and prednisolone in refractory multiple myeloma.
    Kabir AL; Rahman MJ; Begum M; Dipta TF; Baqui MN; Aziz A; Rahman F; Debnath RC; Habib MA
    Mymensingh Med J; 2012 Jan; 21(1):114-9. PubMed ID: 22314465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multiple myeloma].
    Kanoh T
    Rinsho Ketsueki; 1989 Aug; 30(8):1212-5. PubMed ID: 2601036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [IgD-lambda type multiple myeloma associated with IgG-kappa type benign monoclonal gammopathy].
    Shimada H; Nishinarita S; Kishigami Y; Hayama T; Sawada U; Horie T; Nakamura N; Kato M; Hirano M; Nakamura O
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Apr; 18(2):235-40. PubMed ID: 7553059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperammonemia after high-dose chemotherapy and stem cell transplantation.
    Frere P; Canivet JL; Gennigens C; Rebeix JP; Fillet G; Beguin Y
    Bone Marrow Transplant; 2000 Aug; 26(3):343-5. PubMed ID: 10967577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Testicular involvement in IgD multiple myeloma].
    Kawauchi K; Ogasawara T; Yasuyama M; Ohkawa S; Aiba M
    Rinsho Ketsueki; 2001 Nov; 42(11):1128-33. PubMed ID: 11808083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Rheumatoid arthritis and multiple myeloma--the risk of a combination of the 2 diseases].
    Lila AM; Mazurov VI; Novik AA
    Ter Arkh; 1997; 69(2):50-2. PubMed ID: 9173578
    [No Abstract]   [Full Text] [Related]  

  • 31. [IgA-lambda type myeloma complicating with autoimmune hemolytic anemia].
    Nakase T; Morita K; Tomeoku M; Katou M; Kanamaru M; Shirakawa S
    Rinsho Ketsueki; 1990 Dec; 31(12):1967-8. PubMed ID: 2127809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved long-term survival in multiple myeloma. Finnish Leukaemia Group.
    Eur J Haematol; 1989 Nov; 43(5):385-8. PubMed ID: 2612611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The influence of verapamil on platelet function in patients with multiple myeloma].
    Sokołowska B; Dmoszyńska A; Walter-Croneck A; Wojtaszko M
    Pol Merkur Lekarski; 1997 Feb; 2(8):109-10. PubMed ID: 9538652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of gastric amyloidosis developing into Bence-Jones type multiple myeloma, treated effectively by cyclo-VAMP chemotherapy].
    Ayabe T; Maekawa I; Ashida T; Taruishi M; Shibata Y; Namiki M
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2399-403. PubMed ID: 8259860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Assessment of a nitrosurea combined with cyclophosphamide and prednisone versus melphalan and prednisone in the treatment of multiple myeloma (author's transl)].
    Bezares R; Bomchil G; Saslavsky J; Pavlovsky S; Curutchet M; Quiroga Micheo E; Macchi A; Musso A; Suárez A; Pizzolato M
    Sangre (Barc); 1979; 24(3):241-51. PubMed ID: 472966
    [No Abstract]   [Full Text] [Related]  

  • 36. [Intracytoplasmic crystals and Fanconi syndrome in a patient with IgA kappa myeloma].
    Martín Reyes G; García González I; Alférez MJ; Martínez González JM; Frutos MA
    Nefrologia; 2001; 21(2):213-6. PubMed ID: 11464657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to adriamycin and CCNU in a patient with IgD multiple myeloma and myelofibrosis.
    Hartman HA; Skoog D; Foley JF; Stone DB
    Nebr Med J; 1979 Jul; 64(7):201-5. PubMed ID: 112484
    [No Abstract]   [Full Text] [Related]  

  • 38. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
    Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
    Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Complete remission of plasmablastic IgD lambda multiple myeloma induced by continuous infusion of low-dose cytarabine and etoposide].
    Fukuno K; Tsurumi H; Yamada T; Oyama M; Moriwaki H
    Rinsho Ketsueki; 2000 Jun; 41(6):513-8. PubMed ID: 10921352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meningeal myeloma in the absence of systemic disease, and as the initial feature of disease progression.
    Somers LJ; Shaw B; Lyn BE; McMillan AM; Mahendra P
    Clin Lab Haematol; 1998 Jun; 20(3):189-90. PubMed ID: 9681237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.